Related Experiment Video
Updated: Dec 29, 2025
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention
Sara Merlo1, Simona Federica Spampinato1, Grazia Ilaria Caruso1
1Department of Biomedical and Biotechnological Sciences, Section of Pharmacology; University of Catania, Catania, Italy.
Abstract:
Amyloid-β (Aβ) has long been shown to be critical in Alzheimer's disease pathophysiology. Microglia contributes to the earliest responses to Aβ buildup, by direct interaction through multiple receptors. Microglial cells operate Aβ clearance and trigger inflammatory/regenerative processes that take place in the long years of silent disease progression that precede symptomatic appearance. But in time and with aging, the fine balance between pro- and anti-inflammatory activity of microglia deranges, negatively impacting its Aβ-clearing ability. Furthermore, in recent years, microglial activation has proven to be much more complex than the mere dichotomic pro/antiinflammatory polarization previously accepted. Microglia can display a wide spectrum of phenotypes, which can even be mixed. On these bases, it is evident that while pharmacological intervention aiding microglia to prolong its ability to cope with Aβ buildup could be extremely relevant, its feasibility is hampered by such high complexity, which still needs to be completely understood.
Insights
Microglia play a key role in Alzheimer's disease by clearing amyloid-beta (Aβ) plaques. However, aging disrupts microglial function, hindering Aβ clearance and disease progression.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Amyloid-beta (Aβ) accumulation is central to Alzheimer's disease (AD) pathophysiology.
- Microglia, the brain's immune cells, are the first responders to Aβ buildup, mediating clearance and inflammatory responses during early, silent AD progression.
- Aging impairs the delicate balance of microglial pro- and anti-inflammatory activities, compromising their Aβ-clearing capacity.
Purpose of the Study:
- To explore the complex role of microglia in Alzheimer's disease.
- To understand how microglial phenotypes and functions change with aging in the context of Aβ.
- To assess the potential for pharmacological interventions targeting microglial Aβ clearance.
Main Methods:
- This study reviews the current understanding of microglial responses to Aβ.
- It examines the impact of aging on microglial function and phenotype diversity.
- The research synthesizes data on microglial clearance mechanisms and inflammatory signaling.
Main Results:
- Microglia's initial Aβ clearance function declines with age due to dysregulated inflammatory balance.
- Microglial activation is more complex than a simple pro-/anti-inflammatory dichotomy, involving a spectrum of phenotypes.
- Aging leads to impaired microglial Aβ clearance, contributing to AD progression.
Conclusions:
- Targeting microglial function to enhance Aβ clearance is a promising therapeutic strategy for Alzheimer's disease.
- The complexity of microglial phenotypes and their age-related changes presents significant challenges for developing effective pharmacological interventions.
- Further research is needed to fully elucidate microglial complexity for successful therapeutic development in AD.
